Neuramedy
Biotechnology Research
Korea, Kr
3 employees
- Employees
- 3
- Contacts
- 1
- Emails
- 1
Neuramedy Overview
- Headquarters
- Korea, Kr
- Website
- www.neuramedy.com
- Industry
- Biotechnology Research
- Employees
- 3
- Founded
- 2019
- Funding
- 6.7M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Neuramedy
We are researching neuro-degenerative disorder focused on alpha synuclein. Our lead compound is Tomaraliman, a TLR2 agonist for Parkinsons' disease.
Neuramedy Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
Neuramedy Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Seung-Jae Lee | Professor, Seoul National University | Seoul, South Korea, Korea, Republic of |
View
|
| Minsup Lee | Co-ceo & Founder at Neuramedy | Seoul, South Korea, Korea, Republic of |
Email
|
| Jiyong Jung |
View
|
Compare Similar Companies to Neuramedy
Johnson & Johnson
Hospitals And Health Care
Thermo Fisher Scientific
Biotechnology Research
Novo Nordisk
Pharmaceutical Manufacturing
Medpace
Pharmaceutical Manufacturing
Almac Group
Pharmaceutical Manufacturing
GC Genome
Biotechnology Research
ToolGen Inc.
Biotechnology Research
Prazer Therapeutics
Biotechnology Research
Corestem Inc
Multi-signal peer